- A decision aid for an informed choice when patient asks for PSA screening (KCE Reports 224 - 2014)
- Informed choice on breast cancer screening: messages to support informed decision (KCE Reports 216 - 2014)
- Breast cancer screening amongst women aged 70-74 years of age (KCE Reports 176 - 2012)
- Breast cancer screening with mammography for women in the agegroup of 40-49 years (KCE Reports 129 - 2010)
- Identifying women at risk for breast cancer/technical methods for breast cancer screening (KCE Reports 172 - 2012)
- Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome (KCE Reports 236 - 2015)
- Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening (KCE Reports 238 - 2015)
- Statins for the primary prevention of cardiovascular events (KCE Reports 306 -2019)
- The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making (KCE Reports 324 - 2019)
- Cardiovascular pre-participation screening in young athletes (KCE Reports 241 - 2015)
- Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review (KCE Reports 244 - 2015)
- Novel serum biomarkers for the prediction of cardiovascular risk (KCE Reports 201 - 2013)
- Seasonal influenza vaccination: prioritizing children or other target groups? - Part II (KCE Reports 204 - 2013)
- Cost-effectiveness analysis of HPV vaccination of boys in Belgium (KCE Reports 308 - 2019)
- Use of pneumococcal vaccines in the elderly: an economic evaluation (KCE Reports 274 - 2016)
- A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study (KCE Reports 231 - 2014)
- Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium (KCE Reports 151 - 2010)
- Evaluation of universal and targeted hepatitis A vaccination programs in Belgium (KCE Reports 98 - 2008)
- HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment (KCE Reports 64 - 2007)
- Cost-effectiveness analysis of rotavirus vaccination of Belgian infants (KCE Reports 54 - 2007)
- Towards integrated antenatal care for low-risk pregnancy (KCE Reports 326 - 2019)
- How to improve the detection of child abuse in Belgium (KCE Reports 269 - 2016)
- What are the recommended clinical assessment and screening tests during pregnancy? (KCE Reports 248 - 2015)
- Multi criteria decision analysis to select priority diseases for Newborn blood screening (KCE Reports 267 - 2016)
- A national guideline for the prevention of pressure ulcers (KCE Reports 193 - 2013)
- Hepatitis C: Screening and Prevention (KCE Reports 173 - 2012)
- Pharmacological prevention of fragility fractures in Belgium (KCE Reports 159 - 2011)
- Statins in Belgium: utilization trends and impact of reimbursement policies (KCE Reports 141 - 2010)
- Home Monitoring of Infants in Prevention of Sudden Infant Death Syndrome (KCE Reports 46 - 2006)
